Is the risk of ibuprofen or other non-steroidal anti-inflammatory drugs increased in COVID-19?

Joel Vosu; Philip Britton; Annaleise Howard-Jones; David Isaacs; Alison Kesson; Ameneh Khatami; Ben Marais; Claire Nayda; Alexander Outhred

doi:10.1111/jpc.15159

Is the risk of ibuprofen or other non-steroidal anti-inflammatory drugs increased in COVID-19?

J Paediatr Child Health. 2020 Oct;56(10):1645-1646. doi: 10.1111/jpc.15159. Epub 2020 Aug 30.

Authors

Joel Vosu^{1

2}, Philip Britton^{1

2

3

4}, Annaleise Howard-Jones^{1

2}, David Isaacs^{1

2

3

4}, Alison Kesson^{1

2}, Ameneh Khatami^{1

2

3}, Ben Marais^{1

2

3}, Claire Nayda^{1

2}, Alexander Outhred^{1

2}

Affiliations

¹ Department of Infectious Diseases, Children's Hospital at Westmead, Sydney, New South Wales, Australia.
² Department of Microbiology and Infection Control, Children's Hospital at Westmead, Sydney, New South Wales, Australia.
³ Clinical Ethics, Children's Hospital at Westmead, Sydney, New South Wales, Australia.
⁴ Discipline of Child and Adolescent Health, University of Sydney, Sydney, New South Wales, Australia.

PMID: 32862506
DOI: 10.1111/jpc.15159

No abstract available

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
COVID-19
COVID-19 Drug Treatment
Child
Coronavirus Infections / drug therapy*
Humans
Ibuprofen / adverse effects*
Pandemics
Pneumonia, Viral / drug therapy*

Substances

Anti-Inflammatory Agents, Non-Steroidal
Ibuprofen